Dihydroartemisinin inhibits activation of the AIM2 inflammasome pathway and NF-κB/HIF-1α/VEGF pathway by inducing autophagy in A431 human cutaneous squamous cell carcinoma cells

The therapeutic effect of dihydroartemisinin (DHA) against cutaneous squamous cell carcinoma (cSCC) has been previously demonstrated; however, the underlying mechanism remains unclear. This study sought to verify the therapeutic effect of DHA against cSCC and explore its underlying mechanism in A431...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yajie, Li, Zhijia, Teng, Muzhou, Liu, Junlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176175/
https://www.ncbi.nlm.nih.gov/pubmed/34104103
http://dx.doi.org/10.7150/ijms.57167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176175/
https://www.ncbi.nlm.nih.gov/pubmed/34104103
http://dx.doi.org/10.7150/ijms.57167

Ejemplares similares